Azurity Pharmaceuticals, Inc. et al v. Glenmark Pharmaceuticals Limited et al

NPE Status

Practicing Entity

Declaratory Judgment

No

See case in Lex Machina

Civil Action

1:22-cv-01604

Filing Date

Dec 16, 2022

Venue

D.Del.

Termination Date

Mar 17, 2023

US Patent No

Patent Asserters:

Patent Asserter

Arbor Pharmaceuticals, LLC

8 Product company

Azurity Pharmaceuticals, Inc.

8 Product company

Takeda Pharmaceutical Co Ltd

8 Product company

Alleged Infringers:

Glenmark Pharmaceuticals, Inc. (USA)

Glenmark Pharmaceuticals, Ltd.